Vaccine stocks weakened in early trading
Zhifei biology and Kangtai biology fell nearly 5%, while Watson biology, kangxinuo, Anke biology and Fosun medicine fell more than 3%.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 26, 2022 12:26 PM
Healthcare, Financials
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Briefing Feb 17, 2022 10:08 AM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
See more
Read next
Insight
In-depth
Insight
In-depth
Technology
WaveFront Ventures: How Can Chinese Companies Win the Global Robotic Race
Mar 24, 2023 02:02 PM
Insight
In-depth
Technology · Analysis
CIRCUE: AI Drives the Revolution of Energy, Leading a Sustainable Future
Mar 23, 2023 12:26 PM